US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices votes to recommend AREXVY for the prevention of RSV disease in adults aged 60 and older with shared clinical decision making | Business

PHILADELPHIA--(BUSINESS WIRE)--Jun 21, 2023--

Related Keywords

Middlesex ,United Kingdom General ,United Kingdom ,London ,City Of ,Philadelphia ,Pennsylvania ,United States ,Washington ,Brentford ,Hounslow ,Japan ,Kathleen Quinn ,Tony Wood ,James Dodwell ,Jeff Mclaughlin ,Tim Foley ,Josh Williams ,Mick Readey ,Steph Mountifield ,Simon Moore ,Camilla Campbell ,Nick Stone ,Centers For Disease ,Advisory Committee On Immunization Practices ,Agenus Inc ,Antigenics Inc ,Us Centers For Disease ,European Medicines Agency ,European Commission ,Forum Infect Dis ,Human Services ,United States Census Bureau ,National Foundation For Infectious Diseases ,Drug Administration ,Us Department Of Health ,Disease Control ,Advisory Committee ,Immunization Practices ,Chief Scientific Officer ,New England Journal ,Northern Hemisphere ,Mortality Weekly Report ,Safety Information ,Prescribing Information ,Annual Report ,States Census ,Older Adults ,Chronic Medical ,Accessed May ,Respiratory Syncytial ,Englj Med ,Forum Infect ,Syncytial Virus Prefusionf Protein Vaccine ,Investor Relations ,Business Wire ,Business ,